TY  - GEN
AU  - Hoenigl,Martin
AU  - Talento,Alida Fe
AU  - Hoenigl,Martin
AU  - Talento,Alida Fe
TI  - Fungal Infections Complicating COVID-19
SN  - books978-3-0365-0555-8
PY  - 2021///
CY  - Basel, Switzerland
PB  - MDPI - Multidisciplinary Digital Publishing Institute
KW  - Medicine
KW  - bicssc
KW  - SARS-CoV-2
KW  - co-infection
KW  - pulmonary aspergillosis
KW  - ICU
KW  - azole-resistant Aspergillus
KW  - Aspergillus fumigatus
KW  - CAPA
KW  - TR34L98H
KW  - SARS COV-2
KW  - Aspergillus
KW  - novel coronavirus
KW  - superinfection
KW  - risk factors
KW  - prevalence
KW  - challenges
KW  - immune response
KW  - expert statement
KW  - European Confederation of Medical Mycology
KW  - COVID-19
KW  - fungaemia
KW  - Saccharomyces
KW  - co-infections
KW  - invasive aspergillosis
KW  - putative
KW  - probable
KW  - Sars-CoV-2
KW  - PCR
KW  - galactomannan
KW  - classification
KW  - COVID-19 pneumonia
KW  - invasive pulmonary aspergillosis
KW  - diagnosis
KW  - multi-triazole resistance
KW  - COVID-19 associated invasive pulmonary aspergillosis
KW  - coinfection
KW  - diabetes
KW  - bloodstream infection
KW  - Candida glabrata
KW  - echinocandin resistance
KW  - FKS mutation
KW  - candidemia
KW  - candiduria
KW  - oral candidiasis
KW  - mycobiome
KW  - n/a
N1  - Open Access
N2  - Coronavirus disease 2019 (COVID-19), caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), spread globally to pandemic proportions. Although the majority of cases have asymptomatic or mild infections, a significant proportion of cases progress to severe pneumonia and acute respiratory distress syndrome requiring critical care. Opportunistic infections following severe respiratory viral infections have been recognized since the 1918 influenza pandemic. Among critically ill patients with COVID-19, secondary fungal infections caused by Aspergillus and Candida spp. are increasingly described, affecting up to 30% of COVID-19 patients requiring intensive care treatment. This collection of manuscripts focuses on fungal infections complicating COVID-19, including immunological mechanisms and pathogenesis, diagnosis, and treatment
UR  - https://mdpi.com/books/pdfview/book/3658
UR  - https://directory.doabooks.org/handle/20.500.12854/76280
ER  -